FUNARP

¿Por qué cambiar un tratamiento que funciona? Blanca González usó Rituximab por 9 años con éxito. Tras el cambio, su salud retrocedió: dolor y deformidad. 🚫 La salud pública debe priorizar la calidad de vida del paciente. ¡No más retrocesos! @CSSPanama @MINSAPma #Funarp

¡Tus ojos también cuentan! 👀 FUNARP presenta charla práctica: complicaciones oculares en enfermedades reumáticas y la importancia de evaluaciones oftalmológicas periódicas para evitar secuelas visuales. Con Dr. Enrique Giraldo (Reumatólogo) y Dra. Yael Chávez (Oftalmóloga). Sábado 28 marzo, 9:00 am-12:30 pm | Espacio del Emprendedor, Cinta Costera. También: ¿A dónde estamos con el Cannabis Medicinal? Donación B/. 5.00. Inscríbete: 6411-0568 o funarp.org/eventos/ Salud pública que importa. #EquipoFUNARP #FunarpEduca #Funarp #EnfermedadesReumáticasYMusculoesqueléticas

Hoy Día Mundial de la Artritis Idiopática Juvenil. Mundo: 3–400 casos x 100.000 niños <16 años. Panamá y Latam: cifras similares, pero subdiagnóstico frecuente. Síntomas: dolor, hinchazón, rigidez matutina, fatiga, fiebre, erupción, inflamación ocular. Si lo ves → pediatra YA. Autoridades: fortalezcamos detección temprana en Panamá. 💙 #EquipoFUNARP #FunarpEduca #Funarp #EnfermedadesReumáticasYMusculoesqueléticas

En el Día Mundial de la Artritis Idiopática Juvenil (18 mar), desde la Fundación de Artritis Reumatoide de Panamá celebramos la valentía de nuestros niños. Gracias de corazón a: The Cat Cave Gaming por la diversión 🎮 @AmpymePanama por el espacio Dr. Alex Tapia y la Dra. Dorothee Stichweh por su guía y dedicación. Ivis Armien por lo saludable VSweet por lo dulce Ningún niño solo. Juntos podemos más. 💙 #ArtritisIdiopaticaJuvenil #NiñosValientes #PanamáSolidario

Hoy, Día Mundial de Enfermedades Raras: en Panamá, ~240,000 personas viven con estas, incluidas reumáticas raras. FUNARP urge acción: diagnóstico temprano, acceso a tratamientos y apoyo gubernamental para mejorar vidas. Autoridades, inviertan en salud reumática. Únete a la causa. 💪 funarp.org #FunarpEduca #Funarp #EnfermedadesReumáticasYMusculoesqueléticas

Do you still belive that cognitive decline is an inevitable part of aging? A double-blind, randomized clinical trial (the gold standard of science) challenges this narrative. The study found that for adults aged 65-80, daily consumption of wild blueberries improved brain processing speed. Anthocyanins, abundant in wild blueberries, sharpen how quickly your neurons communicate with each other. If a simple dietary shift can measurably upgrade your executive function, why are you still waiting for a pharmaceutical "fix"? Action Plan: 1. Opt for wild blueberries (often found in the freezer aisle) 2. Aim for approximately one cup daily to match the levels used in clinical studies. 3. Make it a non-negotiable part of your morning routine to see the cumulative metabolic benefits. uncnri.org/2022/09/19/new… #HealthyLifestyle #HealthyDiet

¿Por qué cambiar un tratamiento que funciona? Blanca González usó Rituximab por 9 años con éxito. Tras el cambio, su salud retrocedió: dolor y deformidad. 🚫 La salud pública debe priorizar la calidad de vida del paciente. ¡No más retrocesos! @CSSPanama @MINSAPma #Funarp

Conversación FUNARP@FUNARP: En salud, lo barato sale caro. Luris Higuera de FUNARP denuncia fallas en el biosimilar Rituximab. El dolor de los pacientes con Artritis Reumatoide no espera. ¡Prioricen la calidad y farmacovigilancia sobre el precio! 🚫 @MINSAPma @CSSPanama #FUNARP #FunarpEduca

Swedish scientists develop microscopic nanobots that could prevent heart attacks without surgery. These microscopic machines move through blood vessels, locate hardened buildup, and break it apart with incredible precision — restoring blood flow without the need for stents, surgery, or long recovery times. Early trials show that the nanobots can clean arteries far more effectively than today’s procedures, offering a powerful new option for preventing heart attacks and strokes. The technology works by steering the bots with magnetic fields, guiding them directly to blockages that normally require invasive interventions. Once in place, the nanobots gently break the plaque into particles small enough for the body to process naturally, leaving the artery smooth and open. Patients in initial tests saw improved circulation almost instantly, proving just how transformative this approach could be for cardiovascular care. But the breakthrough has sparked controversy in the United States, where cardiologists perform millions of repeat procedures each year to manage plaque buildup. Critics say the adoption of nanobot treatments could dramatically reduce the need for costly surgeries, cutting into billions of dollars in annual revenue from angioplasty, stent replacements, and other recurring interventions. Supporters argue that patient health should come first — and that technology capable of cleaning arteries in minutes should be embraced, not resisted.

New content online: Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials dlvr.it/TQZfgK

Roche Canada announced that Health Canada has approved obinutuzumab (Gazyva) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy. Following four initial doses in the first year, Gazyva can be administered twice yearly buff.ly/9D865jn

Switzerland is drawing worldwide attention after researchers announced a blood-pressure medication that appears to reverse biological aging by as much as fifteen years. Early studies suggest the drug repairs cellular damage, improves metabolic function, and restores markers that typically decline with age. Scientists say the effect isn’t just cosmetic — it reflects deeper changes in how the body heals, regulates stress, and maintains vital organs over time. The discovery came after long-term trials showed patients taking the medication had younger biological ages than their actual birth ages, along with improved cardiovascular health, stronger immune activity, and better energy metabolism. Researchers believe the drug works by reducing inflammation and improving cellular communication, two major factors linked to aging. Participants also showed healthier blood flow to the brain, better memory scores, and enhanced physical resilience compared to control groups. What makes the breakthrough even more significant is its potential accessibility. Because the medication is based on existing blood-pressure treatments, scientists think it could be adapted more easily than an entirely new drug. If further trials confirm its impact on lifespan and age-related decline, Switzerland’s discovery could reshape global approaches to longevity, preventive medicine, and overall health care. The research is still unfolding, but the early results suggest a future where aging may be far more flexible than once believed. A simple pill that protects the heart, restores youth, and prolongs life would mark one of the most remarkable achievements in modern medicine. #LongevityResearch #AntiAging #MedicalBreakthrough #HealthInnovation #FutureMedicine

According to research published in the Journal of Functional Foods, apigenin, a naturally occurring flavonoid found in parsley and chamomile, was shown to induce programmed cell death in human endometrial cancer cells (Ishikawa cells). The study demonstrated that apigenin does more than slow cell growth—it actively pushes cancer cells toward apoptosis, a tightly controlled self-destruct process. According to the findings, this effect occurs through activation of endoplasmic reticulum (ER) stress pathways. By disrupting internal protein-folding balance and cellular stress regulation, apigenin increases pro-apoptotic signaling inside endometrial cancer cells, ultimately leading to their elimination rather than survival or spread.

Dispensing medication in a #rheum practice, possible novel biomarkers for SSc, & GLP-1s—this week in The #Rheumatologist. ▶️ Dispensing Rheumatology Medications from the Practice acr.tw/4rsIl4h ▶️ Possible Novel Biomarkers for Systemic Sclerosis acr.tw/49Q0hzV ▶️ Do GLP-1s Have Benefits for Patients with Rheumatic Disease? acr.tw/4c1VRHr